Home >  Investors Relations >  CryoLife Announces Release Date & Teleconference Call Details for 2017 Third Quarter Financial Results

CryoLife to Present at Two Investor Conferences in September 2017

September 18, 2017 at 8:34 AM EDT

ATLANTA, Sept. 18, 2017 /PRNewswire/ -- CryoLife, Inc.(NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that Pat Mackin, Chairman, President and Chief Executive Officer, will present at two investor conferences in September 2017.

Cryolife logo. (PRNewsFoto/CryoLife, Inc.) (PRNewsFoto/CRYOLIFE_ INC_) (PRNewsFoto/CRYOLIFE, INC.)

The first conference is the Cantor Fitzgerald Global Healthcare Conference in New York.

Event: Cantor Fitzgerald Global Healthcare Conference
Date: Monday, September 25, 2017
Time: 4:45 p.m. ET

The second conference is the Ladenburg Thalmann 2017 Healthcare Conference in New York.

Event: Ladenburg Thalmann 2017 Healthcare Conference
Date: Tuesday, September 26, 2017
Time: 9:00 a.m. ET

The live webcast of the Company's presentations can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page.  An archived copy of the webcasts will be available for 90 days on the same website.

About CryoLife

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac and vascular surgical procedures.  CryoLife markets and sells products in more than 80 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:




CryoLife

The Ruth Group

D. Ashley Lee

Zack Kubow

Executive Vice President, Chief Operating Officer

646-536-7020

and Chief Financial Officer

zkubow@theruthgroup.com

Phone: 770-419-3355


View original content with multimedia:http://www.prnewswire.com/news-releases/cryolife-to-present-at-two-investor-conferences-in-september-2017-300520743.html

SOURCE CryoLife, Inc.